[go: up one dir, main page]

WO2001053312A8 - Novel nucleic acids and polypeptides - Google Patents

Novel nucleic acids and polypeptides

Info

Publication number
WO2001053312A8
WO2001053312A8 PCT/US2000/034263 US0034263W WO0153312A8 WO 2001053312 A8 WO2001053312 A8 WO 2001053312A8 US 0034263 W US0034263 W US 0034263W WO 0153312 A8 WO0153312 A8 WO 0153312A8
Authority
WO
WIPO (PCT)
Prior art keywords
nucleic acids
polypeptides
novel nucleic
novel
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2000/034263
Other languages
French (fr)
Other versions
WO2001053312A1 (en
Inventor
Y Tom Tang
Chenghua Liu
Vinod Asundi
Rui-Hong Chen
Yunqing Ma
Xiaohong B Qian
Feiyan Ren
Dunrui Wang
Jian-Rui Wang
Zhiwei Wang
Tom Wehrman
Chongjun Xu
Aidong J Xue
Yonghong Yang
Jie Zhang
Qing A Zhao
Ping Zhou
Ryle Goodrich
Radoje T Drmanac
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hyseq Inc
Original Assignee
Hyseq Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/620,312 external-priority patent/US6569662B1/en
Application filed by Hyseq Inc filed Critical Hyseq Inc
Priority to CA002402563A priority Critical patent/CA2402563A1/en
Priority to AU2001227284A priority patent/AU2001227284A1/en
Priority to EP00990231A priority patent/EP1242443A4/en
Publication of WO2001053312A1 publication Critical patent/WO2001053312A1/en
Publication of WO2001053312A8 publication Critical patent/WO2001053312A8/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/775—Apolipopeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The present invention provides novel nucleic acids, novel polypeptide sequences encoded by these nucleic acids and uses thereof.
PCT/US2000/034263 1999-12-23 2000-12-26 Novel nucleic acids and polypeptides Ceased WO2001053312A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
CA002402563A CA2402563A1 (en) 1999-12-23 2000-12-26 Novel nucleic acids and polypeptides
AU2001227284A AU2001227284A1 (en) 2000-01-21 2000-12-26 Novel nucleic acids and polypeptides
EP00990231A EP1242443A4 (en) 1999-12-23 2000-12-26 NEW NUCLEIC ACIDS AND POLYPEPTIDES

Applications Claiming Priority (18)

Application Number Priority Date Filing Date Title
US47127599A 1999-12-23 1999-12-23
US09/471,275 1999-12-23
US48872500A 2000-01-21 2000-01-21
US09/488,725 2000-01-21
US55231700A 2000-04-25 2000-04-25
US09/552,317 2000-04-25
US59804200A 2000-06-20 2000-06-20
US09/598,042 2000-07-09
US09/620,312 US6569662B1 (en) 2000-01-21 2000-07-19 Nucleic acids and polypeptides
US09/620,312 2000-07-19
US09/653,450 2000-08-03
US65345000A 2000-08-31 2000-08-31
US66219100A 2000-09-14 2000-09-14
US09/662,191 2000-09-14
US69303600A 2000-10-19 2000-10-19
US09/693,036 2000-10-19
US72734400A 2000-11-29 2000-11-29
US09/727,344 2000-11-29

Publications (2)

Publication Number Publication Date
WO2001053312A1 WO2001053312A1 (en) 2001-07-26
WO2001053312A8 true WO2001053312A8 (en) 2002-06-20

Family

ID=27578844

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/034263 Ceased WO2001053312A1 (en) 1999-12-23 2000-12-26 Novel nucleic acids and polypeptides

Country Status (3)

Country Link
EP (1) EP1242443A4 (en)
CA (1) CA2402563A1 (en)
WO (1) WO2001053312A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7033790B2 (en) 2001-04-03 2006-04-25 Curagen Corporation Proteins and nucleic acids encoding same

Families Citing this family (200)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999040100A1 (en) 1998-02-09 1999-08-12 Human Genome Sciences, Inc. 45 human secreted proteins
US20020137890A1 (en) * 1997-03-31 2002-09-26 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US6960433B1 (en) 1998-10-19 2005-11-01 Diadexus, Inc. Method of diagnosing, monitoring, staging, imaging and treating prostate cancer
US6369197B1 (en) 1998-11-20 2002-04-09 Millennium Pharmaceuticals, Inc. Potassium channel interactors and uses therefor
US7078481B1 (en) 1998-11-20 2006-07-18 Wyeth Potassium channel interactors and uses therefor
US7109292B2 (en) 1999-03-08 2006-09-19 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
DK1607402T3 (en) * 1999-03-08 2007-04-16 Genentech Inc Tumor Treatment Compositions and Methods
US8410248B2 (en) 1999-03-12 2013-04-02 Human Genome Sciences Inc. HWBAO62 polypeptides
US6242419B1 (en) * 1999-03-25 2001-06-05 Genesis Research & Development Corporation Ltd. Compositions isolated from stromal cells and methods for their use
US7083791B2 (en) 1999-03-25 2006-08-01 Genesis Research & Development Corporation Limited Methods for enhancing immune responses by fibroblast growth factor receptor 5 polypeptides
US7034132B2 (en) 2001-06-04 2006-04-25 Anderson David W Therapeutic polypeptides, nucleic acids encoding same, and methods of use
AU5446900A (en) 1999-05-28 2000-12-18 Immunex Corporation Novel murine and human kinases
EP1623992A3 (en) * 1999-09-01 2006-05-10 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
EP1686134A3 (en) * 1999-12-01 2006-08-09 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US7423127B2 (en) * 1999-12-09 2008-09-09 Genentech, Inc. Antibodies to a polypeptide encoded by a nucleic acid overexpressed in melanoma
US20090176722A9 (en) 2000-01-28 2009-07-09 Shiv Srivastava Androgen-regulated PMEPA1 gene and polypeptides
ATE435277T1 (en) * 2000-02-11 2009-07-15 Millennium Pharm Inc 18477, A HUMAN PROTEIN KINASE AND USE THEREOF
US6479270B1 (en) * 2000-02-14 2002-11-12 Pe Corporation (Ny) Isolated human phosphatase proteins, nucleic acid molecules encoding human phosphatase proteins, and uses thereof
WO2001060857A2 (en) * 2000-02-17 2001-08-23 Aventis Pharma S.A. Compositions useful for regulating parkin gene activity
JP2003525610A (en) * 2000-03-02 2003-09-02 キュラゲン コーポレイション Gene G12L related to thermal response
US20020111307A1 (en) * 2000-06-23 2002-08-15 Glucksmann Maria Alexandra 46508, a novel human peptidyl-tRNA hydrolase family member and uses thereof
US20040214758A1 (en) 2000-03-24 2004-10-28 Meyers Rachel E. Novel human hydrolase family members and uses thereof
JP4750999B2 (en) * 2000-03-31 2011-08-17 アベンティス・ファーマスーティカルズ・インコーポレイテツド Nuclear factor κB inducer
GB0018307D0 (en) 2000-07-26 2000-09-13 Aventis Pharm Prod Inc Polypeptides
WO2001079467A2 (en) * 2000-04-12 2001-10-25 The United States Of America, As Represented By Secretary Of The Department Of Health & Human Services Identification of a renal nadph oxidase
US7183075B2 (en) * 2000-04-14 2007-02-27 Vanderbilt University Purified and isolated potassium-chloride cotransporter nucleic acids and polypeptides and therapeutic and screening methods using same
WO2001081559A2 (en) * 2000-04-26 2001-11-01 Millennium Pharmaceuticals, Inc. 26335, a novel human serine/threonine dehydratase and uses thereof
US20030083244A1 (en) * 2000-04-26 2003-05-01 Vernet Corine A.M. Novel proteins and nucleic acids encoding same
US6461846B2 (en) 2000-05-30 2002-10-08 Pe Corporation Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
DE10027170A1 (en) * 2000-05-31 2001-12-13 Schering Ag Human PEM as a target for fertility control
US6965018B2 (en) 2000-06-06 2005-11-15 Bristol-Myers Squibb Company Antibodies directed to B7-related polypeptide, BSL-2
WO2001096375A2 (en) * 2000-06-16 2001-12-20 Millennium Pharmaceuticals, Inc. 33358, a novel human ankyrin family member and uses thereof
FR2810673B1 (en) * 2000-06-26 2004-10-08 Univ Toulouse HUMAN MITOCHONDRIAL DYNAMINE MSP1 AND ITS USE IN THERAPEUTICS
WO2002002761A2 (en) * 2000-06-30 2002-01-10 Millennium Pharmaceuticals, Inc. 57658, a human uridine kinase and uses thereof
WO2002006331A2 (en) * 2000-07-18 2002-01-24 Millennium Pharmaceuticals, Inc. 14087, a serine protease molecule and uses therefor
AU2001277202A1 (en) * 2000-07-26 2002-02-05 Applied Genomics, Inc. Bstp-ras/rerg protein and related reagents and methods of use thereof
EP1307553A2 (en) * 2000-08-01 2003-05-07 Oregon Health & Science University Mammalian dna binding membrane-associated protein-encoding gene and uses
WO2002010217A2 (en) 2000-08-02 2002-02-07 The Johns Hopkins University Endothelial cell expression patterns
WO2002012339A2 (en) * 2000-08-03 2002-02-14 Incyte Genomics, Inc. Sequences for integrin alpha-8
ES2269430T3 (en) * 2000-08-04 2007-04-01 Ludwig Institute For Cancer Research SUPPRESSOR GEN.
CA2705366A1 (en) 2000-08-28 2002-03-07 Agensys, Inc. Nucleic acid and corresponding protein entitled 85p1b3 useful in treatment and detection of cancer
WO2002018566A2 (en) * 2000-08-31 2002-03-07 Bayer Aktiengesellschaft Regulation of human l-asparaginase-like enzyme
EP1328636A2 (en) * 2000-09-01 2003-07-23 Nuvelo Inc. Nucleic acids and polypeptides
AU2001287448A1 (en) 2000-09-01 2002-03-13 The Governing Council Of The University Of Toronto Proteins related to schizophrenia and uses thereof
WO2002024911A2 (en) * 2000-09-19 2002-03-28 Millennium Pharmaceuticals, Inc. 63760, a novel human transporter and uses thereof
AU2001293830A1 (en) * 2000-09-27 2002-04-08 Bayer Aktiengesellschaft Regulation of human aminotransferase-like enzyme
KR20030074604A (en) * 2000-09-27 2003-09-19 밀레니엄 파머슈티컬스 인코퍼레이티드 Potassium channel interactors and uses therefor
WO2002026957A2 (en) * 2000-09-28 2002-04-04 Bayer Aktiengesellschaft Regulation of a human serine protease
GB0024086D0 (en) * 2000-10-02 2000-11-15 Inpharmatica Ltd Proteinase
US6911336B2 (en) * 2000-10-18 2005-06-28 Immunex Corporation GNK interacting amino acid decarboxylase and methods of use thereof
AUPR107800A0 (en) * 2000-10-27 2000-11-23 University Of Sydney, The Peptide and nucleic acid molecule ii
AUPR121300A0 (en) * 2000-11-03 2000-11-30 Monash University Cell division autoantigen (CDA) polypeptides, gene sequences and uses thereof
US20030078376A1 (en) * 2000-11-07 2003-04-24 Board Of Regents, The University Of Texas System Methods and compositions relating to muscle specific sarcomeric calcineurin-binding proteins (calsarcins)
JP2004537981A (en) 2000-11-16 2004-12-24 エモリー・ユニバーシティ Mitogen oxygenase regulator
WO2002040651A2 (en) * 2000-11-17 2002-05-23 Bayer Aktiengesellschaft A human trna-specific adenosine deaminase
EP1209229A1 (en) * 2000-11-21 2002-05-29 Klaus-Peter Department of Psychiatry and Psychotherapy University of Würzburg Lesch Gene involved in schizophrenia
AU2002239229A1 (en) 2000-12-05 2002-06-18 Wisconsin Alumni Research Foundation Receptor for b. anthracis toxin
US20040072997A1 (en) * 2000-12-20 2004-04-15 Alsobrook John P. Therapeutic polypeptides, nucleic acids encoding same, and methods of use
JPWO2002050269A1 (en) * 2000-12-21 2004-04-22 株式会社ジェノックス創薬研究所 Testing methods for allergic diseases
AU2002249876A1 (en) * 2000-12-22 2002-08-19 Millennium Pharmaceuticals, Inc. 25828, a novel human aminopeptidase and uses therefor
WO2002053716A2 (en) * 2001-01-03 2002-07-11 Bayer Aktiengesellschaft Regulation of human ornithine decarboxylase
AUPR278301A0 (en) 2001-01-31 2001-02-22 Bionomics Limited A novel gene
JPWO2002057444A1 (en) 2001-01-22 2004-05-20 近藤　科江 Human apoptosis-related gene and its product, human apoptosis-related protein
AU2002305921A1 (en) * 2001-01-22 2002-10-08 Millennium Pharmaceuticals, Inc. Fbh58295fl, a novel human amino acid transporter and uses thereof
US6686176B2 (en) * 2001-01-23 2004-02-03 Applera Corporation Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
US7601825B2 (en) 2001-03-05 2009-10-13 Agensys, Inc. Nucleic acid and corresponding protein entitled 121P1F1 useful in treatment and detection of cancer
WO2002072830A2 (en) * 2001-02-09 2002-09-19 Incyte Genomics, Inc. Proteins associated with cell growth, differentiation, and death
WO2002064777A2 (en) * 2001-02-14 2002-08-22 Axaron Bioscience Ag Proteins 7b6 and 11b4 and dna sequences encoding the same
WO2002064786A1 (en) * 2001-02-15 2002-08-22 Mochida Pharmaceutical Co., Ltd. Novel gene tcif
EP1575984A4 (en) 2001-02-16 2006-09-06 Bristol Myers Squibb Co Identification and cloning of a novel human gene, ret16, involved in the intracellular signaling cascade
US6461843B1 (en) 2001-02-16 2002-10-08 Applera Corporation Isolated nucleic acid molecules encoding human enzyme proteins, and uses thereof
GB0104440D0 (en) * 2001-02-22 2001-04-11 Oxford Biomedica Ltd Novel genes
US6924358B2 (en) 2001-03-05 2005-08-02 Agensys, Inc. 121P1F1: a tissue specific protein highly expressed in various cancers
WO2002074913A2 (en) * 2001-03-16 2002-09-26 Incyte Genomics, Inc. Nucleic acid-associated proteins
US8231878B2 (en) 2001-03-20 2012-07-31 Cosmo Research & Development S.P.A. Receptor trem (triggering receptor expressed on myeloid cells) and uses thereof
US8981061B2 (en) 2001-03-20 2015-03-17 Novo Nordisk A/S Receptor TREM (triggering receptor expressed on myeloid cells) and uses thereof
WO2002077219A1 (en) * 2001-03-26 2002-10-03 Lexicon Genetics Incorporated Novel human asparaginases and polynucleotides encoding the same
US6867019B2 (en) * 2001-03-27 2005-03-15 Applera Corporation Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof
CA2442134A1 (en) 2001-03-29 2002-10-10 Celltech R & D, Inc. Compositions and methods for diagnosing or treating psoriasis
US20030044813A1 (en) * 2001-03-30 2003-03-06 Old Lloyd J. Cancer-testis antigens
FR2823221B1 (en) 2001-04-06 2004-04-02 Univ Pasteur SEQUENCES ASSOCIATED WITH RETINAL DEGENERATION AND APPLICATIONS
AU2002308139A1 (en) * 2001-04-12 2002-10-28 Bayer Aktiengesellschaft Regulation of human methionine aminopeptidase-like protein
EP1258495A1 (en) * 2001-05-09 2002-11-20 Millennium Pharmaceuticals, Inc. 98359, A sodium channel beta 4 subunit, and uses therefor
WO2002097093A1 (en) * 2001-05-30 2002-12-05 Chiba-Prefecture Nucleic acids isolated in neuroblastoma
AU2002312624A1 (en) * 2001-07-06 2003-01-21 Incyte Genomics, Inc. Drug metabolizing enzymes
AU2002325196A1 (en) * 2001-07-09 2003-01-29 Kobenhavns Universitet Epsti1, a gene induced by epithelial-stromal interaction in human breast cancer
IL159872A0 (en) * 2001-07-26 2004-06-20 Genset Sa Gmg-2 polypeptides and their use
US7413870B2 (en) * 2001-08-01 2008-08-19 Rigel Pharmaceuticals, Incorporated SAK: modulation of cellular proliferation for treatment of cancer
FR2828209A1 (en) * 2001-08-01 2003-02-07 Cytomics Systems New nucleic acid encoding HECT-domain polypeptides, useful e.g. for treatment of cancer or inflammation, also new proteins, antibodies and modulators
US20030104385A1 (en) * 2001-08-02 2003-06-05 Evans Glen A. Nucleic acids and encoded polypeptides associated with bipolar disorder
JP4102898B2 (en) * 2001-08-23 2008-06-18 独立行政法人科学技術振興機構 Hematopoietic stem cell growth regulator and polynucleotide encoding the same
JP2003135063A (en) * 2001-08-24 2003-05-13 Chiba Prefecture New gene NEDL-1
CA2459013C (en) * 2001-08-27 2011-01-04 Japan Science And Technology Agency Proteins having effects of controlling cell migration and cell death
WO2003020947A2 (en) * 2001-08-31 2003-03-13 Millennium Pharmaceuticals, Inc. Mid 9002, a human sulfatase family member and uses therefor
WO2003099318A2 (en) 2002-05-29 2003-12-04 DeveloGen Aktiengesellschaft für entwicklungsbiologische Forschung Pancreas-specific proteins
KR101008758B1 (en) * 2001-09-18 2011-01-14 제넨테크, 인크. Methods for Diagnosing and Treating Tumors and Compositions for the Same
AU2008201995A1 (en) * 2001-09-18 2008-05-29 Genentech, Inc. Compositions and methods for the diagnosis and treament of tumor
JP4232423B2 (en) * 2001-09-28 2009-03-04 第一三共株式会社 Novel ubiquitin-specific protease
JP2005514916A (en) * 2001-10-03 2005-05-26 イミュネックス・コーポレーション Human and murine cytokine polypeptides
WO2003038093A2 (en) * 2001-10-30 2003-05-08 Bayer Healthcare Ag Regulation of human l-serine dehydratase
US20030124593A1 (en) * 2001-10-31 2003-07-03 Millennium Pharmaceuticals, Inc. Methods and compositions for the treatment and diagnosis of cellular proliferation disorders using 25943
US7166713B2 (en) * 2001-12-11 2007-01-23 Texas Techn University Variant cleavage stimulation factor and its encoding nucleic acid
JP2005514013A (en) * 2001-12-19 2005-05-19 ミレニアム・ファーマシューティカルズ・インコーポレイテッド Methods and compositions in treating pain and painful disorders using 1465, 1587, 2146, 2207, 32838, 336, and 52908
WO2003057867A2 (en) * 2002-01-10 2003-07-17 Bayer Healthcare Ag Regulation of human fatty acid coa ligase-like amp-binding enzyme
WO2003060129A1 (en) * 2002-01-16 2003-07-24 Bayer Healthcare Ag Regulation of human fatty acid coa ligase-like amp-binding enzyme
AU2003210158A1 (en) * 2002-01-16 2003-07-30 Bayer Aktiengesellschaft Regulation of human fatty acid coa ligase-like amp-binding enzyme
AU2003205174A1 (en) * 2002-01-17 2003-09-02 Incyte Genomics, Inc. Molecules for disease detection and treatment
WO2003072773A1 (en) * 2002-02-08 2003-09-04 Seikagaku Corporation Fused protein having glucuronyl transferase activity
JP2003250550A (en) * 2002-02-25 2003-09-09 Nissui Pharm Co Ltd Fat cell differentiation-related gene and protein
GB0206684D0 (en) * 2002-03-21 2002-05-01 Babraham Inst Novel proteins
US7193069B2 (en) 2002-03-22 2007-03-20 Research Association For Biotechnology Full-length cDNA
EP1490484A2 (en) * 2002-03-27 2004-12-29 Bayer HealthCare AG Further bmp-2 inducible kinases and the uses thereof
AU2003215460A1 (en) * 2002-03-28 2003-10-13 Qlt Inc. Cancer associated protein kinases and their uses
EP1491628A4 (en) * 2002-03-29 2006-10-18 Nat Inst Of Advanced Ind Scien NOVEL GALACTOSE TRANSFERASES AND THEIR PEPTIDES, AND NUCLEIC ACID ENCODING THE SAME TRANSFERASES
WO2003082342A1 (en) * 2002-04-01 2003-10-09 National Institute Of Advanced Industrial Science And Technology Application of kiaa0172 gene to treatment and diagnosis of diseases and drug discovery
NZ535925A (en) * 2002-04-16 2008-06-30 Genentech Inc An isolated antibody that binds to a particular polypeptide
WO2003093826A2 (en) * 2002-04-29 2003-11-13 Clinigenetics Assays for identifying cholesterol - lowering molecules
US7009038B2 (en) * 2002-05-02 2006-03-07 Univ. Of Medicine & Dentistry Of N.J. pDJA1, a cardiac specific gene, corresponding proteins, and uses thereof
JP2005528918A (en) 2002-06-07 2005-09-29 アースロン・リミテッド FcγRIIa transgenic animal model for autoimmune disease
MXPA04012560A (en) * 2002-06-13 2005-10-19 Wyeth Corp Inhibitors of inflammatory gene activity and cholesterol biosynthesis.
GB0214543D0 (en) * 2002-06-24 2002-08-07 Ares Trading Sa Proteins
EP1552845A4 (en) * 2002-06-26 2006-06-07 Takeda Pharmaceutical SUBSTANCES FOR THE PREVENTION AND / OR TREATMENT OF CANCER
US20060110384A1 (en) * 2002-07-10 2006-05-25 Yuji Matsuzawa Novel proteins and use thereof
JP2004097199A (en) * 2002-07-15 2004-04-02 Keio Gijuku Tumor antigen screening method
WO2004009622A2 (en) * 2002-07-19 2004-01-29 Cellzome Ag Protein complexes of cellular networks underlying the development of cancer and other diseases
AU2003254081A1 (en) 2002-07-24 2004-02-09 New York University Truncated rgr in t cell malignancy
GB0217631D0 (en) * 2002-07-30 2002-09-11 Inpharmatica Ltd Proteins
WO2004013320A1 (en) * 2002-07-30 2004-02-12 Bayer Healthcare Ag Regulation of human methyltransferase
AU2003266271A1 (en) * 2002-08-13 2004-03-19 Bayer Healthcare Ag Regulation of human esterase
US20070269800A9 (en) * 2002-08-28 2007-11-22 Heinz Von Der Kammer Diagnostic and therapeutic use of foap-13 polynucleotides and polypeptides for neurodegenerative diseases
EP1396544A1 (en) * 2002-09-06 2004-03-10 Academisch Ziekenhuis Bij De Universiteit Van Amsterdam Nucleic acids encoding human thyroid dehalogenases
EP1539232A1 (en) * 2002-09-12 2005-06-15 Pharmexa A/S Immunization against autologous ghrelin
WO2004032614A2 (en) * 2002-09-13 2004-04-22 Ingenium Pharmaceuticals Ag Animal with modification of cytoplasmic dynein heavy chain 1 gene
WO2004028558A1 (en) * 2002-09-27 2004-04-08 Takeda Pharmaceutical Company Limited Preventives/remedies for neurodegenerative disease
US7662917B2 (en) 2002-09-30 2010-02-16 Ludwig Institute For Cancer Research Human sarcoma-associated antigens
US7560537B2 (en) * 2002-09-30 2009-07-14 Ludwig Institute For Cancer Research Human sarcoma-associated antigens
WO2004039980A1 (en) * 2002-10-30 2004-05-13 Cancer Research Technology Limited Agents modulating mal activity
WO2004039974A1 (en) * 2002-10-30 2004-05-13 Takeda Pharmaceutical Company Limited Novel protein and dna thereof
CA2506633A1 (en) * 2002-11-21 2004-06-10 Wyeth Composition and method for treating lupus nephritis
GB0228337D0 (en) * 2002-12-05 2003-01-08 Yorkshire Cancer Res Campaign Replication protein
DE60336015D1 (en) 2002-12-24 2011-03-24 Univ Beijing Human genes associated with cancer, including encoded products and applications thereof
US20050015821A1 (en) * 2003-02-21 2005-01-20 Phenomix Corporation Sensin polypeptides, encoding nucleic acids, mutations, and methods of their identification and use
JP4445291B2 (en) * 2003-03-10 2010-04-07 武田薬品工業株式会社 Novel protein and its DNA
AU2003901511A0 (en) * 2003-03-28 2003-04-17 Bionomics Limited Nucleic acid molecules associated with angiogenesis II
EP1464651A1 (en) * 2003-04-03 2004-10-06 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Dystrophin-related protein (Drop1), a marker for carcinomas
US7829682B1 (en) 2003-04-30 2010-11-09 Incyte Corporation Human β-adrenergic receptor kinase nucleic acid molecule
CN1244595C (en) * 2003-05-14 2006-03-08 中国科学院上海生命科学研究院 A kind of tumor suppressor protein and its application
US7863042B2 (en) 2003-06-18 2011-01-04 Chugai Seiyaku Kabushiki Kaisha Fucose transporter
FR2843753A1 (en) * 2003-06-20 2004-02-27 Gene Signal Antisense nucleic molecule useful as inhibitor of angiogenesis in the treatment of angiogenic disorders, e.g., rheumatoid arthritis, atherosclerosis and endometriosis
WO2004113532A1 (en) * 2003-06-21 2004-12-29 Shigeki Higashiyama Protein for screening cytostatic agent, method of screening cytostatic agent and cytostatic agent
US20060205031A1 (en) * 2003-07-07 2006-09-14 1) Universiteit Utrecht Holding B.V. Newly identified cholinephosphotransferases and ethanolaminephosphotransferases
US7294704B2 (en) 2003-08-15 2007-11-13 Diadexus, Inc. Pro108 antibody compositions and methods of use and use of Pro108 to assess cancer risk
CA2540006A1 (en) * 2003-09-23 2005-04-07 Meyer Pharmaceuticals, Llc Treating inflammation using a biological agent that causes cells to release cytokine receptors
JP2005168338A (en) * 2003-12-09 2005-06-30 Japan Science & Technology Agency Novel protein calfogrin, gene encoding the same, drug, and target substance
US20050186577A1 (en) 2004-02-20 2005-08-25 Yixin Wang Breast cancer prognostics
WO2005090574A1 (en) * 2004-03-19 2005-09-29 Genomidea Inc. Vascular endothelial growth inhibiting gene
GB0407587D0 (en) * 2004-04-02 2004-05-05 Univ Nottingham Trent Cancer associated antigens
JP4908402B2 (en) * 2004-09-24 2012-04-04 オンコセラピー・サイエンス株式会社 Method for diagnosing non-small cell lung cancer by tRNA-dihydrouridine synthase activity of URLC8
CN101068936A (en) * 2004-11-22 2007-11-07 惠氏公司 Methods and systems for prognosis and treatment of solid tumors
GB0426146D0 (en) 2004-11-29 2004-12-29 Bioxell Spa Therapeutic peptides and method
DE102004059781A1 (en) * 2004-12-10 2006-06-22 Sanofi-Aventis Deutschland Gmbh Use of serum / glucocorticoid-regulated kinase
EP2295601A1 (en) 2005-02-10 2011-03-16 Oncotherapy Science, Inc. Method of diagnosing bladder cancer
EP1734118A1 (en) * 2005-06-15 2006-12-20 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Identification of JAK/STAT pathway modulating genes by genome wide RNAi screening
WO2007028631A1 (en) * 2005-09-09 2007-03-15 H. Lundbeck A/S Genetic risk factor for neurodevelopmental disorders and their complications
US20070071755A1 (en) * 2005-09-27 2007-03-29 David Balasundaram Novel nucleolar GTPases and method for controlling proliferation of cells
US20090305255A1 (en) * 2006-02-01 2009-12-10 Hiroshima University Substrate Protein for M-Phase Kinase and use Thereof
EP1815863A1 (en) * 2006-02-03 2007-08-08 Nederlandse Organisatie voor toegepast-natuurwetenschappelijk Onderzoek TNO Use of TLR3 agonists for the treatment of neurodegenerative disorders
WO2007095113A2 (en) 2006-02-10 2007-08-23 Massachusetts Institute Of Technology Cpg15 and cpg15-2 compounds and inhibitors as insulin receptor and insulin-like growth factor receptor agonists and antagonists
US8933209B2 (en) * 2006-04-26 2015-01-13 Abbvie Inc. Dep2 and its uses in major depressive disorder and other related disorders
US8318795B2 (en) 2007-03-01 2012-11-27 Cedars-Sinai Medical Center Antioxidant polymers containing [1,2]-dithiolane moieties and uses thereof
AU2008259792B2 (en) * 2007-06-03 2013-08-22 Oncotx, Inc. Cancer related isoforms of components of transcription factor complexes as biomarkers and drug targets
EP2027889A1 (en) * 2007-06-05 2009-02-25 Institut National De La Sante Et De La Recherche Medicale (Inserm) New neuronal viability factor and use thereof
WO2009086547A1 (en) 2008-01-03 2009-07-09 Cedars-Sinai Medical Center Antioxidant nanosphere comprising [1,2]-dithiolane moieties
US7833721B2 (en) 2008-03-14 2010-11-16 Exagen Diagnostics, Inc. Biomarkers for inflammatory bowel disease and irritable bowel syndrome
EP2300451A1 (en) 2008-06-02 2011-03-30 Cedars-Sinai Medical Center Nanometer-sized prodrugs of nsaids
ES2529060T3 (en) 2008-11-24 2015-02-16 Cedars-Sinai Medical Center Antioxidant derivatives of camptothecin and antioxidant antineoplastic nanospheres thereof
HRP20231525T1 (en) 2009-02-20 2024-03-15 Astellas Pharma Inc. PROCEDURES AND PREPARATIONS FOR THE DIAGNOSIS AND TREATMENT OF CANCER
HUE035516T2 (en) 2009-11-11 2018-05-28 Ganymed Pharmaceuticals Gmbh Antibodies specific for claudin 6 (CLDN6)
EP2404936A1 (en) 2010-07-06 2012-01-11 Ganymed Pharmaceuticals AG Cancer therapy using CLDN6 target-directed antibodies in vivo
JP6276176B2 (en) 2011-05-13 2018-02-07 ガニメド ファーマシューティカルズ ゲーエムベーハー Antibodies for cancer treatment
KR101949186B1 (en) * 2011-05-19 2019-02-18 도레이 카부시키가이샤 Immunity inducing agent
WO2013104798A1 (en) * 2012-01-12 2013-07-18 Cemm - Center For Molecular Medicine Of The Austrian Academy Of Sciences Modulators of immune responses
US9550830B2 (en) 2012-02-15 2017-01-24 Novo Nordisk A/S Antibodies that bind and block triggering receptor expressed on myeloid cells-1 (TREM-1)
EP3456742A1 (en) 2012-02-15 2019-03-20 Novo Nordisk A/S Antibodies that bind peptidoglycan recognition protein 1
PL2814844T3 (en) 2012-02-15 2017-12-29 Novo Nordisk A/S Antibodies that bind and block triggering receptor expressed on myeloid cells-1 (trem-1)
US20130288980A1 (en) * 2012-04-02 2013-10-31 Buck Institute For Research On Aging Targeting senescent and cancer cells for selective killing by interference with foxo4
WO2015014376A1 (en) 2013-07-31 2015-02-05 Biontech Ag Diagnosis and therapy of cancer involving cancer stem cells
KR20250110365A (en) 2014-07-17 2025-07-18 노보 노르디스크 에이/에스 Site directed mutagenesis of trem-1 antibodies for decreasing viscosity
EP2977758A1 (en) * 2014-07-24 2016-01-27 Université De Nice Sophia Antipolis Methods and kits for monitoring membranous nephropathy
AR102333A1 (en) * 2014-08-19 2017-02-22 Regeneron Pharma EFFICIENT SELECTIVITY OF RECOMBINED PROTEINS
CN107257802B (en) 2014-12-19 2021-11-23 豪夫迈·罗氏有限公司 Identification of transglutaminase substrates and uses thereof
CA2971402C (en) 2014-12-19 2023-08-01 F. Hoffmann-La Roche Ag Microbial transglutaminases, substrates therefor and methods for the use thereof
US11054425B2 (en) 2014-12-19 2021-07-06 Roche Sequencing Solutions, Inc. System and method for identification and characterization of transglutaminase species
GB201509134D0 (en) * 2015-05-28 2015-07-15 Electrophoretics Ltd Biomolecules involved in Alzheimer's disease
CR20200608A (en) 2016-04-21 2021-01-20 Immatics Biotechnologies Gmbh IMMUNOTHERAPY AGAINST MELANOMA AND OTHER TYPES OF CANCER (Divisional 2018-0551)
SG11201808629UA (en) 2016-04-21 2018-11-29 Immatics Biotechnologies Gmbh Immunotherapy against melanoma and other cancers
CR20250022A (en) 2018-04-02 2025-02-25 Bristol Myers Squibb Co Anti-TREM-1 antibodies, nucleic acids, and vectors thereof (Divisional 2020-0450)
GB201807831D0 (en) * 2018-05-15 2018-06-27 Univ College Cardiff Consultants Ltd Cancer Vaccine
EP4110350A4 (en) * 2020-02-27 2024-04-03 The George Washington University, A Congressionally Chartered Not-For-Profit Corporation COBRA1/NELF-B AS AN ENHANCER OF THE EFFECTIVENESS OF CD8+ T-CELL THERAPY
WO2022109376A2 (en) * 2020-11-23 2022-05-27 United States Goverment as represented by the Department of Veterans Affairs Compositions and methods for suppressing msut2

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5175095A (en) * 1989-07-19 1992-12-29 Calgene, Inc. Ovary-tissue transcriptional factors
DK1490386T3 (en) * 1998-03-10 2008-12-15 Genentech Inc New polypeptide and nucleic acids encoding this

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7033790B2 (en) 2001-04-03 2006-04-25 Curagen Corporation Proteins and nucleic acids encoding same

Also Published As

Publication number Publication date
EP1242443A4 (en) 2005-06-22
EP1242443A1 (en) 2002-09-25
WO2001053312A1 (en) 2001-07-26
CA2402563A1 (en) 2001-07-26

Similar Documents

Publication Publication Date Title
WO2001053312A8 (en) Novel nucleic acids and polypeptides
WO2001053455A3 (en) Novel nucleic acids and polypeptides
WO2001075067A3 (en) Novel nucleic acids and polypeptides
WO2001057188A3 (en) Novel nucleic acids and polypeptides
WO2001057190A3 (en) Novel nucleic acids and polypeptides
WO2002022660A3 (en) Novel nucleic acids and polypeptides
WO2001066689A3 (en) Novel nucleic acids and polypeptides
WO2002031111A3 (en) Novel nucleic acids and polypeptides
WO2001088088A3 (en) Novel nucleic acids and polypeptides
WO2002059260A3 (en) Nucleic acids and polypeptides
WO2003054152A3 (en) Novel nucleic acids and polypeptides
WO2003025148A3 (en) Novel nucleic acids and polypeptides
WO2002070539A3 (en) Novel nucleic acids and polypeptides
WO2003023013A3 (en) Novel nucleic acids and polypeptides
WO2002081731A3 (en) Novel nucleic acids and polypeptides
WO2004009834A3 (en) Novel nucleic acids and secreted polypeptides
WO2004080148A3 (en) Novel nucleic acids and polypeptides
WO2003029271A3 (en) Novel nucleic acids and polypeptides
WO2001079449A3 (en) Novel nucleic acids and polypeptides
WO2002018424A3 (en) Nucleic acids and polypeptides
WO2004087874A3 (en) Novel nucleic acids and polypeptides
WO2003080795A3 (en) Novel nucleic acids and secreted polypeptides
WO2001002571A3 (en) An interleukin-1 receptor antagonist and uses thereof
WO2005049806A3 (en) Novel nucleic acids and polypeptides
WO2002044340A3 (en) Novel nucleic acids and polypeptides

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US US US US US US US US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: C1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US US US US US US US US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: C1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

CFP Corrected version of a pamphlet front page
CR1 Correction of entry in section i

Free format text: PAT. BUL. 30/2001 UNDER (30) ADD "09/471275, 23.12.99, US"

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WR Later publication of a revised version of an international search report
WWE Wipo information: entry into national phase

Ref document number: 2402563

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2000990231

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2000990231

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 2000990231

Country of ref document: EP

DPE2 Request for preliminary examination filed before expiration of 19th month from priority date (pct application filed from 20040101)